Suppr超能文献

急性呼吸衰竭患者接受无创通气时的呼吸困难:患病率、危险因素和预后影响:一项前瞻性观察研究。

Dyspnoea in patients receiving noninvasive ventilation for acute respiratory failure: prevalence, risk factors and prognostic impact: A prospective observational study.

机构信息

Sorbonne Universités, UPMC Université Paris 06, INSERM, UMRS1158, Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France.

Service de Pneumologie et Réanimation Médicale (Dépt "R3S"), Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Paris, France.

出版信息

Eur Respir J. 2018 Aug 9;52(2). doi: 10.1183/13993003.02637-2017. Print 2018 Aug.

Abstract

Dyspnoea is a frequent and intense symptom in intubated patients, but little attention has been paid to dyspnoea during noninvasive mechanical ventilation in the intensive care unit (ICU).The objectives of this study were to quantify the prevalence, intensity and prognostic impact of dyspnoea in patients receiving noninvasive ventilation (NIV) for acute respiratory failure (ARF) based on secondary analysis of a prospective observational cohort study in patients who received ventilatory support for ARF in 54 ICUs in France and Belgium. Dyspnoea was measured by a modified Borg scale.Among the 426 patients included, the median (interquartile range) dyspnoea score was 4 (3-5) on admission and 3 (2-4) after the first NIV session (p=0.001). Dyspnoea intensity ≥4 after the first NIV session was associated with the Sequential Organ Failure Assessment Score (odds ratio (OR) 1.12, p=0.001), respiratory rate (OR 1.03, p=0.032), anxiety (OR 1.92, p=0.006), leaks (OR 2.5, p=0.002) and arterial carbon dioxide tension (OR 0.98, p=0.025). Dyspnoea intensity ≥4 was independently associated with NIV failure (OR 2.41, p=0.001) and mortality (OR 2.11, p=0.009), but not with higher post-ICU burden and altered quality of life.Dyspnoea is frequent and intense in patients receiving NIV for ARF and is associated with a higher risk of NIV failure and poorer outcome.

摘要

呼吸困难是插管患者常见且强烈的症状,但在重症监护病房(ICU)接受无创机械通气(NIV)的患者中,呼吸困难问题很少受到关注。本研究的目的是通过对法国和比利时 54 个 ICU 中接受 ARF 通气支持的患者进行前瞻性观察队列研究的二次分析,定量评估接受 NIV 治疗的 ARF 患者呼吸困难的发生率、强度和预后影响。呼吸困难通过改良 Borg 量表进行测量。在纳入的 426 例患者中,入院时呼吸困难评分中位数(四分位距)为 4(3-5),首次 NIV 治疗后为 3(2-4)(p=0.001)。首次 NIV 治疗后呼吸困难强度≥4 与序贯器官衰竭评估评分(优势比(OR)1.12,p=0.001)、呼吸频率(OR 1.03,p=0.032)、焦虑(OR 1.92,p=0.006)、漏气(OR 2.5,p=0.002)和动脉血二氧化碳分压(OR 0.98,p=0.025)有关。呼吸困难强度≥4 与 NIV 失败(OR 2.41,p=0.001)和死亡率(OR 2.11,p=0.009)独立相关,但与 ICU 后负担增加和生活质量改变无关。接受 ARF 治疗的 NIV 患者中呼吸困难频繁且强烈,与 NIV 失败和预后不良的风险增加相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验